ATTENTION BHVN SHAREHOLDERS: Investors who lost money on Biohaven Ltd. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESS Newswire / March 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd.
Hosted on MSN1mon
Pfizer settles Biohaven kickback case with DOJ for $60M
Pfizer (NYSE:PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to physicians to induce prescriptions for its migraine drug Nurtec ODT. The U.S ...
Longmont Leader10d
Colorado Doctors Allegedly Accepted Illegal Kickbacks in Migraine Drug Scheme
Four Colorado physicians are named in a lawsuit settlement involving pharmaceutical company Biohaven, which allegedly paid ...
BHVN STOCK ALERT: Levi & Korsinsky Notifies Biohaven Ltd. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd.
Yahoo Finance11d
Biohaven’s pivotal bipolar drug trial fails, stock takes hit
Biohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial, sinking the company’s stock price. The US-based biotech shared the ...
Nasdaq1mon
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
Biohaven previously received both Fast-Track and Orphan Drug Designation (ODD ... TRPM3 antagonism for migraine and neuropathic pain; TYK2/JAK1 inhibition for neuroinflammatory disorders ...
U.S. News & World Report1mon
Pfizer to Pay $59.7 Million Over Kickbacks for Migraine Drug
Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the migraine drug Nurtec ...